SCHEMBL3467017

SCHEMBL3467017

COC(=O)C(CCCc1ccccc1)CCc1ccc(-c2cccc(C#N)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 3/20 0.57
MMP13 P45452 2/20 0.57
MME P08473 1/20 0.45
FOLH1 Q04609 1/20 0.43
FAAH O00519 1/20 0.43
MCHR1 Q99705 1/20 0.42
ADAMTS4 O75173 1/20 0.42
C3AR1 Q16581 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
XDH P47989 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
PRSS1 P07477 1/20 0.40
CTSG P08311 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467000 0.93 MMP12 (0.51) MMP12MMP13ADAMTS4MMP2MMP3
SCHEMBL3466543 0.90 MMP12 (0.51) MMP12MMP13MMEFAAHMMP2
SCHEMBL7932591 0.88 MMP12 (0.63) MMP12MMP13MMEFOLH1FAAH
SCHEMBL7928277 0.87 MMP12 (0.64) MMP12MMP13MMEFOLH1FAAH
SCHEMBL1860059 0.87 MMP12 (0.53) MMP12MMP13MMEMMP2MMP3
SCHEMBL1859451 0.86 FFAR1 (0.44) MMP12MMP13FOLH1MMP2MMP3
SCHEMBL3468279 0.85 HCAR2 (0.47) MMP12MMEFOLH1FFAR1FFAR4
SCHEMBL3466565 0.84 GPR34 (0.54) MMP12MMP13ADAMTS4FFAR1FFAR4
SCHEMBL3466501 0.84 HCAR2 (0.52) MMEMMP3
SCHEMBL3466739 0.84 MMP2 (0.52) MMP12MMEMMP2MMP3PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed